The growth is being fueled by various factors, chief among them being the huge wave of patent expirations of key branded drugs, which presents opportunities for generic substitutes. Further, the increased global incidence of chronic diseases demands affordable treatment alternatives, further enhancing the market for generics. A crucial regulatory step in bringing generic drugs to market involves demonstrating their bioequivalence to an already approved product known as the Reference Listed Drug (RLD). New generic versions are rigorously compared to the RLD to ensure they perform identically within the body.
Transparency
Competitive Price
On Time Delivery
Unconditional Support
This is where Arkon Solutions offers you an indispensable service. Expertizing in the worldwide sourcing and supply of RLDs, Arkon Solutions makes certain that businesses are connected with the necessary products for their bioequivalence testing and regulatory approvals. Taking advantage of a great network of proven suppliers in major regions like EU, USA, Canada, South East Asia, China, Japan Arkon Solutions is able to procure pharmaceutical products directly and securely, serving the needs of most major pharmaceutical companies worldwide and streamlining a critical phase of generic drug development.
Reference Listed Drugs (RLDs) are essential for pharmaceutical companies to conductresearch and development projects, as well as for clinical trials and bioequivalence studies.At our company, we specialize in providing RLD sourcing services to these veryorganizations, ensuring that they receive well- compliant and validated drugs in a timely, secure and efficient manner.
We understand the critical importance of correctly handling Reference Listed Drugs (RLDs),encompassing meticulous transportation and storage practices to unfailingly preserve their quality and integrity. Leveraging our safe and secured access to global storage and distribution networks, we manage the entire shipping and distribution process with utmost care and under proper survillence . This enables us to offer customised tailored logistic solutions, designed to meet each client's unique requirements while consistently ensuring the quality assurance and efficacy of these vital pharmaceutical drugs.
As a pharmaceutical company Arkon Solutions is deeply entrenched in the complexities of global drug development and supply chains.Our expertise extends significantly into the intricate process of customs clearance, particularly for Reference Listed Drugs
(RLDs).
Arkon Solutions have a profound experience with import/export regulations regarding controlled substances, temperature-sensitive commodities, and requisite documentation like Certificates of Analysis (CoA), import
authorization, andregulatory clearances as per pharmaceutical formulation.
At Arkon Solutions we have extensive experience in offering complete licensing assistance specifically designed for the RLD process.
Our expertise goes beyond mere procurement; we are expert strategic sources of genuine
RLD lots with special care in handling, proper storage, and detailed documentation needed to comply with strict regulatory requirements.
Seizing on our expansive network and deeper knowledge of the world's global
pharmaceutical supply chain and regulatory guidelines, we process this critical phase for our customers, allowing them to effectively pursue their bioequivalence studies while moving their Abbreviated New Drug Application
(ANDA) submissions forward securely, supported by our dependable and compliant RLD services.
Arkon Health has a team of qualified and specialized Support team to guide you. Our specialists cater to the specific medical needs of the patients and healthcare professionals to ensure tailored solutions.
Proudly recognized by global quality standards. These certifications demonstrate our commitment to safety, excellence, and customer trust.
Explore Compliance
